Compare FMC Corp (FMC) vs Huntington Bancshares Incorporated (HBAN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
FMC Corp vs Huntington Bancshares Incorporated — how do they compare? FMC Corp trades at $11.36 (market cap $1.36B), while Huntington Bancshares Incorporated trades at $18.53 (market cap $36.74B). The key difference: Huntington Bancshares Incorporated is far larger — about 27× FMC Corp's market cap, and Huntington Bancshares Incorporated pays the higher dividend (3.42%). Which is the better fit depends on your goals.
| FMC | HBAN | |
|---|---|---|
Market Cap | $1.36B | $36.74B |
Sector | Basic Materials | Financials |
52-Week High | $43.90 | $19.27 |
52-Week Low | $10.72 | $15.02 |
Enterprise Value | $5.50B | — |
Dividend Yield | 2.95% | 3.42% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FMC Corporation (FMC) trades at $11.61, up 8.3% today, but remains in a challenging fundamental position with a net income margin of -72.93% and negative ROE of -80.78% for 2025. The company is actively restructuring, securing a $400 million minority investment from Tessenderlo Group and planning a $114 million property sale to reduce its $3.03 billion long-term debt. Technical indicators are bearish, with the stock trading near key support at $11. Recent news highlights progress on its new herbicide, rimisoxafen, including a regulatory submission to the EPA and a partnership with Corteva.
The outlook is cautious. While aggressive debt reduction and new product pipelines offer potential, deep losses and declining revenue pose significant risks. The analyst consensus is mixed (47.6% Buy, 50% Hold) with a $16 price target, suggesting modest upside if turnaround efforts succeed, but high execution risk remains the primary concern for investors.
Huntington Bancshares (HBAN) trades at $18.48, up 3.53% today, with a bullish technical outlook and strong analyst consensus. Recent Q1 2026 earnings beat expectations, and the company shows revenue growth to $8.13B in 2025. Key financials include a P/E of 13.94 and net income margin of 25.13%. Positive news highlights expansion in Texas and a recent banking tech award, supporting investor optimism.
HBAN presents a favorable investment case with upside to the $20.25 consensus price target, driven by earnings growth and strategic acquisitions. Risks include integration challenges from M&A and competitive pressures in regional banking. The stock's valuation remains reasonable, but investors should monitor execution on synergy targets and interest rate impacts on net interest margin.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About FMC Corp
FMC is a pure-play crop chemical company. The company has diversified its sales to create a balanced crop chemical portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop chemical companies and will continue to develop new products, with a focus on biologicals, through its research and development pipeline.
Read more on FMC →About Huntington Bancshares Incorporated
Huntington Bancshares is a regional bank holding company headquartered in Columbus, Ohio. The bank has a network of branches and ATMs across eight Midwestern states. Founded in 1866, Huntington National Bank and its affiliates provide consumer, small-business, commercial, treasury management, wealth management, brokerage, trust, and insurance services. Huntington also provides auto dealer, equipment finance, national settlement, and capital market services that extend beyond its core states.
Read more on HBAN →
